Ronald C. Renaud Jr., Director at Akebia Therapeutics, Inc. (AKBA), bought 5,000 shares at $11.92 ($60K) on 2014-12-02, disclosed to the SEC on 2014-12-02.
Open-market purchase of $60k AKBA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |